J0175 – Injection, donanemab-azbt, 2 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0175
- Long description
- Injection, donanemab-azbt, 2 mg
- Short description
- Inj, donanemab-azbt, 2 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- July 2, 2024
- Last change
- July 2, 2024 – No change
Frequently asked questions
What is HCPCS code J0175?
J0175 is a HCPCS Level II code for injection, donanemab-azbt, 2 mg.
Does Medicare cover J0175?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0166 – Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg
- J0167 – Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg
- J0168 – Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg
- J0169 – Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg
- J0171 – Injection, adrenalin, epinephrine, 0.1 mg
- J0172 – Injection, aducanumab-avwa, 2 mg
- J0173 – Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg
- J0174 – Lecanemab-irmb, for intravenous injection, 1 mg
- J0177 – Injection, aflibercept hd, 1 mg
- J0178 – Injection, aflibercept, 1 mg
- J0179 – Injection, brolucizumab-dbll, 1 mg
- J0180 – Injection, agalsidase beta, 1 mg
- J0184 – Injection, amisulpride, 1 mg
- J0185 – Injection, aprepitant, 1 mg
- J0190 – Injection, biperiden lactate, per 5 mg
- J0200 – Injection, alatrofloxacin mesylate, 100 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.